>
✏️ Posts:
16,730
| 1. |
COVID19 |
Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults
2023-04-01 13:34:20 EST
Source
|
|
|
| 2. |
COVID19 |
Your outpatient has COVID-19: what are their treatment options in the current SARS-CoV-2 variant climate?
2023-04-01 10:17:49 EST
Source
|
|
|
| 3. |
COVID19 |
Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
2023-04-01 07:24:32 EST
Source
|
|
|
| 4. |
COVID19 |
COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample
2023-04-01 06:20:55 EST
Source
|
|
|
| 5. |
COVID19 |
A National Survey of Children, Adults, and the Elderly in the Fourth Wave of the COVID-19 Pandemic to Compare Acute and Post-COVID-19 Conditions in Saudi Arabia
2023-04-01 05:30:43 EST
Source
|
|
|
| 6. |
COVID19 |
Human disturbance increases coronavirus prevalence in bats
2023-03-31 16:26:23 EST
Source
|
|
|
| 7. |
COVID19 |
Pseudomonas aeruginosa Bloodstream Infections in SARS-CoV-2 Infected Patients: A Systematic Review
2023-03-31 08:57:01 EST
Source
|
|
|
| 8. |
COVID19 |
Assessing the Outcomes of Patients with Severe SARS-CoV-2 Infection after Therapeutic Plasma Exchange by Number of TPE Sessions
2023-03-31 06:42:56 EST
Source
|
|
|
| 9. |
COVID19 |
Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study
2023-03-31 05:30:02 EST
Source
|
|
|
| 10. |
COVID19 |
Rapid flow cytometric analysis of fibrin amyloid microclots in Long COVID
2023-03-30 11:31:55 EST
Source
|
|
|
| 11. |
COVID19 |
SARS-CoV-2 Infection and Clinical Signs in Cats and Dogs from Confirmed Positive Households in Germany
2023-03-30 08:33:46 EST
Source
|
|
|
| 12. |
COVID19 |
Mitigation behavior prior to COVID-19 vaccination availability is associated with COVID-19 infection and time to vaccination
2023-03-30 07:30:39 EST
Source
|
|
|
| 13. |
COVID19 |
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID
2023-03-30 06:59:53 EST
Source
|
|
|
| 14. |
COVID19 |
Epidemic efficacy of Covid-19 vaccination against Omicron: An innovative approach using enhanced residual recurrent neural network
2023-03-30 06:35:00 EST
Source
|
|
|
| 15. |
COVID19 |
Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
2023-03-30 05:30:15 EST
Source
|
|
|
| 16. |
COVID19 |
mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5 - Nature Communications
2023-03-29 22:30:21 EST
Source
|
|
|
| 17. |
COVID19 |
A multicentre study reveals dysbiosis in the microbial co-infection and antimicrobial resistance gene profile in the nasopharynx of COVID-19 patients
2023-03-29 08:49:21 EST
Source
|
|
|
| 18. |
COVID19 |
Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study
2023-03-29 07:28:26 EST
Source
|
|
|
| 19. |
COVID19 |
Extraction-free clinical detection of SARS-CoV-2 virus from saline gargle samples using Hamilton STARlet liquid handler
2023-03-29 06:49:03 EST
Source
|
|
|
| 20. |
COVID19 |
An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial
2023-03-28 23:26:50 EST
Source
|
|
|
| 21. |
COVID19 |
WHO revises COVID-19 vaccine recommendations for Omicron-era
2023-03-28 19:56:56 EST
Source
|
|
|
| 22. |
COVID19 |
SARS-CoV-2 ORF3c suppresses immune activation by inhibiting innate sensing
2023-03-28 19:16:01 EST
Source
|
|
|
| 23. |
COVID19 |
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
2023-03-28 10:15:56 EST
Source
|
|
|
| 24. |
COVID19 |
Spatial–temporal distribution of incidence, mortality, and case-fatality ratios of coronavirus disease 2019 and its social determinants in Brazilian municipalities
2023-03-28 07:57:07 EST
Source
|
|
|
| 25. |
COVID19 |
Stress native T1 and native T2 mapping compared to myocardial perfusion reserve in long-term follow-up of severe Covid-19
2023-03-28 06:59:26 EST
Source
|
|
|
| 26. |
COVID19 |
Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study
2023-03-28 05:47:31 EST
Source
|
|
|
| 27. |
COVID19 |
Great deal Brand new cases of 440 3M Aura N95 1870+ $300/Case when buying Bulk
2023-03-27 21:42:22 EST
Source
|
|
|
| 28. |
COVID19 |
IgG4 Antibodies Induced by mRNA Vaccines Generate Immune Tolerance to SARS-CoV-2’spike Protein by Suppressing the Immune System
2023-03-27 13:37:28 EST
Source
|
|
|
| 29. |
COVID19 |
Walgreens COVID Index
2023-03-27 11:41:02 EST
Source
|
|
|
| 30. |
COVID19 |
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
2023-03-27 09:40:57 EST
Source
|
|
|
| 31. |
COVID19 |
Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana
2023-03-27 08:54:17 EST
Source
|
|
|
| 32. |
COVID19 |
Weekly Scientific Discussion Thread - March 27, 2023
2023-03-27 08:00:32 EST
Source
|
|
|
| 33. |
COVID19 |
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort
2023-03-27 07:47:35 EST
Source
|
|
|
| 34. |
COVID19 |
Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
2023-03-27 06:44:46 EST
Source
|
|
|
| 35. |
COVID19 |
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19
2023-03-26 18:11:20 EST
Source
|
|
|
| 36. |
COVID19 |
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
2023-03-26 15:22:52 EST
Source
|
|
|
| 37. |
COVID19 |
Impact of persistent D-dimer elevation following recovery from COVID-19
2023-03-26 15:09:33 EST
Source
|
|
|
| 38. |
COVID19 |
COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study
2023-03-26 08:37:38 EST
Source
|
|
|
| 39. |
COVID19 |
Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates
2023-03-26 07:44:23 EST
Source
|
|
|
| 40. |
COVID19 |
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
2023-03-26 06:43:55 EST
Source
|
|
|
| 41. |
COVID19 |
Evaluation of SARS-CoV-2 ORF7a Deletions from COVID-19-Positive Individuals and Its Impact on Virus Spread in Cell Culture
2023-03-26 05:11:50 EST
Source
|
|
|
| 42. |
COVID19 |
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
2023-03-25 14:33:54 EST
Source
|
|
|
| 43. |
COVID19 |
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France
2023-03-25 08:47:55 EST
Source
|
|
|
| 44. |
COVID19 |
Cardiopulmonary Exercise Testing in Children and Young Adolescents after a Multisystem Inflammatory Syndrome: Physical Deconditioning or Residual Pathology?
2023-03-25 07:35:48 EST
Source
|
|
|
| 45. |
COVID19 |
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study
2023-03-25 06:50:29 EST
Source
|
|
|
| 46. |
COVID19 |
Computational prediction of interactions between Paxlovid and prescription drugs
2023-03-25 05:44:10 EST
Source
|
|
|
| 47. |
COVID19 |
Unraveling the Underlying Molecular Mechanism of 'Silent Hypoxia' in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway
2023-03-24 09:28:34 EST
Source
|
|
|
| 48. |
COVID19 |
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452
2023-03-24 08:28:10 EST
Source
|
|
|
| 49. |
COVID19 |
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
2023-03-24 06:32:35 EST
Source
|
|
|
| 50. |
COVID19 |
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
2023-03-24 05:39:25 EST
Source
|
|
|
| 51. |
COVID19 |
Former CDC director testifies that COVID-19 most likely originated from Wuhan lab </span>Smith, Burgess introduce legislation to allow US citizens the right to sue Chinese Communist Party for its COVID-19 misrepresentation campaign #Covid-19 #ccpvirus
2023-03-24 02:58:32 EST
Source
|
|
|
| 52. |
COVID19 |
Former CDC director testifies that COVID-19 most likely originated from Wuhan lab Smith, Burgess introduce legislation to allow US citizens the right to sue Chinese Communist Party for its COVID-19 misrepresentation campaign | U.S. Representative
2023-03-24 02:54:59 EST
Source
|
|
|
| 53. |
COVID19 |
Nirmatrelvir and the Risk of Post–COVID-19 Condition
2023-03-24 01:09:15 EST
Source
|
|
|
| 54. |
COVID19 |
Risk Factors for Post−COVID-19 Condition
2023-03-24 01:04:46 EST
Source
|
|
|
| 55. |
COVID19 |
Prion-like Domains in Eukaryotic Viruses
2023-03-23 09:44:20 EST
Source
|
|
|
| 56. |
COVID19 |
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
2023-03-23 08:51:32 EST
Source
|
|
|
| 57. |
COVID19 |
Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial
2023-03-23 07:57:30 EST
Source
|
|
|
| 58. |
COVID19 |
SARS-CoV-2 wastewater-based epidemiology in an enclosed compound: A 2.5-year survey to identify factors contributing to local community dissemination
2023-03-23 06:47:52 EST
Source
|
|
|
| 59. |
COVID19 |
Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
2023-03-23 05:19:08 EST
Source
|
|
|
| 60. |
COVID19 |
Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town
2023-03-22 09:18:54 EST
Source
|
|
|
| 61. |
COVID19 |
Deaths from undetected COVID-19 infections as a fraction of COVID-19 deaths can be used for early detection of an upcoming epidemic wave
2023-03-22 08:08:37 EST
Source
|
|
|
| 62. |
COVID19 |
Stabilization of SARS-CoV-2 RNA in wastewater via rapid RNA extraction
2023-03-22 06:52:35 EST
Source
|
|
|
| 63. |
COVID19 |
Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
2023-03-22 05:39:04 EST
Source
|
|
|
| 64. |
COVID19 |
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
2023-03-21 14:47:04 EST
Source
|
|
|
| 65. |
COVID19 |
Safety and Effectiveness of SA58 Nasal Spray against SARS-CoV-2 family transmission: an exploratory single-arm trial
2023-03-21 14:25:06 EST
Source
|
|
|
| 66. |
COVID19 |
A cross-sectional analysis of the predictors of COVID-19 vaccine uptake and vaccine hesitancy in Iraq
2023-03-21 08:11:27 EST
Source
|
|
|
| 67. |
COVID19 |
Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration
2023-03-21 07:26:10 EST
Source
|
|
|
| 68. |
COVID19 |
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
2023-03-21 06:02:41 EST
Source
|
|
|
| 69. |
COVID19 |
Genetic evidence of susceptible wildlife in SARS-CoV-2 positive samples at the Huanan Wholesale Seafood Market, Wuhan: Analysis and interpretation of data released by the Chinese Center for Disease Control
2023-03-20 19:43:53 EST
Source
|
|
|
| 70. |
COVID19 |
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age
2023-03-20 10:34:21 EST
Source
|
|
|
| 71. |
COVID19 |
COVID-19 and non-Hodgkin’s lymphoma: A common susceptibility pattern?
2023-03-20 08:47:34 EST
Source
|
|
|
| 72. |
COVID19 |
Weekly Scientific Discussion Thread - March 20, 2023
2023-03-20 08:00:31 EST
Source
|
|
|
| 73. |
COVID19 |
Impact of the COVID-19 pandemic on emergent stroke care in Beijing, China
2023-03-20 07:37:08 EST
Source
|
|
|
| 74. |
COVID19 |
The effect of SARS-CoV-2 variant on respiratory features and mortality
2023-03-20 06:53:24 EST
Source
|
|
|
| 75. |
COVID19 |
When should healthcare workers with COVID-19 return to work? An analysis of follow-up antigen test results after a positive COVID test
2023-03-20 05:30:35 EST
Source
|
|
|
| 76. |
COVID19 |
Effectiveness of fourth dose of COVID-19 mRNA vaccine in elderly population during Omicron BA.2 and BA.5 circulation: nationwide cohort study in Korea (K-COVE)
2023-03-19 09:53:21 EST
Source
|
|
|
| 77. |
COVID19 |
Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection
2023-03-19 08:27:46 EST
Source
|
|
|
| 78. |
COVID19 |
Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients
2023-03-19 06:49:03 EST
Source
|
|
|
| 79. |
COVID19 |
Role of IP-10 to predict clinical progression and response to IL-6 blockade with Sarilumab in early COVID-19 pneumonia. A subanalysis of the SARICOR clinical trial
2023-03-19 05:47:45 EST
Source
|
|
|
| 80. |
COVID19 |
Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine
2023-03-18 21:36:05 EST
Source
|
|
|
| 81. |
COVID19 |
Severity and geographical disparities of post-COVID-19 symptoms among the Vietnamese general population: a national evaluation
2023-03-18 09:23:54 EST
Source
|
|
|
| 82. |
COVID19 |
A neural signature of exposure to masked faces after 18 months of COVID-19
2023-03-18 07:16:02 EST
Source
|
|
|
| 83. |
COVID19 |
Are covered faces eye-catching for us? The impact of masks on attentional processing of self and other faces during the COVID-19 pandemic
2023-03-18 07:12:31 EST
Source
|
|
|
| 84. |
COVID19 |
Cognitive impairment in people with previous COVID-19 infection: A scoping review
2023-03-18 05:43:51 EST
Source
|
|
|
| 85. |
COVID19 |
Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections
2023-03-17 09:27:01 EST
Source
|
|
|
| 86. |
COVID19 |
Immunity of heterologous and homologous boosted or convalescent individuals against Omicron BA.1, BA.2 and BA.4/5 variants
2023-03-17 08:18:08 EST
Source
|
|
|
| 87. |
COVID19 |
Total and subgenomic RNA viral load in patients infected with SARS-CoV-2 Alpha, Delta, and Omicron variants
2023-03-17 07:00:57 EST
Source
|
|
|
| 88. |
COVID19 |
Appropriate outcome settings for the effectiveness of oral zinc treatment for Coronavirus Disease-2019
2023-03-17 06:01:03 EST
Source
|
|
|
| 89. |
COVID19 |
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
2023-03-17 03:58:25 EST
Source
|
|
|
| 90. |
COVID19 |
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
2023-03-16 22:56:22 EST
Source
|
|
|
| 91. |
COVID19 |
Booster mRNA vaccination post-SARS-CoV-2 infection enhances functional qualities of T cell immunity
2023-03-16 17:06:45 EST
Source
|
|
|
| 92. |
COVID19 |
Breakthrough in COVID research: link between immune cells and long COVID
2023-03-16 13:59:55 EST
Source
|
|
|
| 93. |
COVID19 |
Post-truth epistemic beliefs rooted in the Dark Factor of Personality are associated with higher COVID-19 vaccination refusal
2023-03-16 09:36:13 EST
Source
|
|
|
| 94. |
COVID19 |
Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
2023-03-16 08:25:11 EST
Source
|
|
|
| 95. |
COVID19 |
Automated prediction of COVID-19 severity upon admission by chest X-ray images and clinical metadata aiming at accuracy and explainability
2023-03-16 07:04:58 EST
Source
|
|
|
| 96. |
COVID19 |
COVID-19 associated cognitive impairment: A systematic review
2023-03-16 05:54:30 EST
Source
|
|
|
© Copyright hackingthevirus.com
2022-2023 Release Version 1.11162020
Return to top ►
© Copyright hackingai.app 2022-2023 Release Version 1.01202023
Return to top ►
